Trial Outcomes & Findings for Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women (NCT NCT02246114)
NCT ID: NCT02246114
Last Updated: 2017-01-16
Results Overview
The primary outcome is the difference in serum cotinine levels between the intervention and control groups at the end of the trial.
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
1 participants
Primary outcome timeframe
1 year
Results posted on
2017-01-16
Participant Flow
Participant milestones
| Measure |
Arm A
no CO monitor
|
Arm B
CO monitor
|
|---|---|---|
|
Overall Study
STARTED
|
1
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
| Measure |
Arm A
no CO monitor
|
Arm B
CO monitor
|
|---|---|---|
|
Overall Study
miscarriage
|
1
|
0
|
Baseline Characteristics
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
Baseline characteristics by cohort
| Measure |
Arm A
n=1 Participants
no CO monitor
|
Arm B
CO monitor
|
Total
n=1 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32 years
n=5 Participants
|
—
|
32 years
n=5 Participants
|
|
Gender
Female
|
1 Participants
n=5 Participants
|
—
|
1 Participants
n=5 Participants
|
|
Gender
Male
|
0 Participants
n=5 Participants
|
—
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 yearPopulation: Only 1 subject enrolled in this study and she terminated early due to miscarriage at 9 weeks.
The primary outcome is the difference in serum cotinine levels between the intervention and control groups at the end of the trial.
Outcome measures
Outcome data not reported
Adverse Events
Arm A (no CO Monitor)
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
Arm B (CO Monitor)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Arm A (no CO Monitor)
n=1 participants at risk
no CO monitor
|
Arm B (CO Monitor)
CO monitor
|
|---|---|---|
|
General disorders
headache
|
100.0%
1/1 • Number of events 1
|
—
0/0
|
Additional Information
Richard S. Legro, M.D.
The Milton S. Hershey Medical Center
Phone: 717-531-6210
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place